MELISSA SPEARS: Open Payments
NPI 1790911469 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,100 in 121 payments from 17 companies in 2025. Trend: 2023 $2,826 · 2024 $4,628 · 2025 $4,100
Food & beverage: $2,996Travel & lodging: $1,104
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 18 | $1,710 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $620 |
| Axsome Therapeutics, Inc. | 25 | $467 |
| ABBVIE INC. | 10 | $239 |
| Vanda Pharmaceuticals Inc. | 5 | $226 |
| Neurocrine BioSciences, Inc. | 6 | $210 |
| Otsuka America Pharmaceutical, Inc. | 14 | $177 |
| Corium, LLC | 7 | $151 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| Lundbeck LLC | 4 | $68 |
Products named: SPRAVATO, CAPLYTA, Auvelity, REXULTI, VRAYLAR, INGREZZA, Azstarys, FANAPT.
Industry payments across TN — which companies pay providers there.
